跳至主要内容
临床试验/NCT04738084
NCT04738084已完成不适用

Randomized Controlled Trial of the Meru Health Program Versus Waitlist Control for Adults With Depression

Meru Health, Inc.2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年8月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
2
主要终点
Depression

研究概览

简要总结

This is a randomized controlled trial (RCT) of the Meru Health Program (MHP) versus a waitlist (WL) control group, which will be offered access to the MHP after the waitlist period (12 weeks) is over, for adults with depression. The Meru Health Program (MHP) is a 12-week mobile mental health intervention delivered via Smartphone app that includes components of several evidence-based treatments (Cognitive Behavioral Therapy, Behavioral Activation Therapy, Mindfulness Meditation) and also several promising therapies (heart rate variability-biofeedback [HRVB], nutritional psychiatry, sleep training) that is overseen by a licensed clinical therapist.

详细描述

Title: Randomized Controlled Trial of the Meru Health Program versus Waitlist Control for Adults with Depression

Study Description: This is a randomized controlled trial (RCT) of the Meru Health Program (MHP) versus a waitlist (WL) control group, which will be offered access to the MHP after the waitlist period (12 weeks) is over, for adults with depression.

Objectives*:

Primary Objective: To compare changes in depressive symptoms and reduction in clinically significant depression at the end of the program and compare between those in the MHP group versus WL group

Secondary Objectives: To compare changes in anxiety, worker productivity, burnout symptoms, resilience, insomnia, quality of life, days spent engaging with the program per week and hours spent in various program activities per week between those in the MHP group versus WL group

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Data analyst will be blind to study group

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • Own a Smartphone
  • Lives in Colorado

排除标准

  • Screen positive for a psychotic disorder, bipolar disorder, alcohol or drug use disorder, or suicidal plans

结局指标

主要结局

Depression

时间窗: 12 weeks

Mean change in Patient Health Questionnaire-9 item depression scale during the program. Scores range from 0 to 27, with higher scores indicative of more depression.

次要结局

  • Anxiety(12 weeks)
  • Quality of life as measured by the EQ-5D(12 weeks)
  • Resilience(12 weeks)
  • Worker Productivity and Activity Impairment(12 weeks)
  • Insomnia(12 weeks)
  • Burnout(12 weeks)
  • Patient-reported adverse events(during the 12-week intervention)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验